The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Primer-Directed Enzymatic Amplification of DNA with a Thermostable DNA Polymerase
Saiki, R. K., Gelfand, D. H., Stoffel, S., Scharf, S. J., Higuchi, R., Horn, G. T., Mullis, K. B., & Erlich, H. A. (1988) · Science · doi:10.1126/science.2448875 · Cited by 17,719
Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms
Malkin, D., Li, F. P., Strong, L. C., Fraumeni, J. F., Nelson, C. E., Kim, D. H., Kassel, J., Gryka, M. A., Bischoff, F. Z., Tainsky, M. A., et al. (1990) · Science · doi:10.1126/science.1978757 · Cited by 3,765
Mutations in the p53 gene occur in diverse human tumour types
Nigro, J. M., Baker, S. J., Preisinger, A. C., Jessup, J. M., Hosteller, R., Cleary, K., Signer, S. H., Davidson, N., Baylin, S., Devilee, P., et al. (1989) · Nature · doi:10.1038/342705a0 · Cited by 2,733
Ames, B. N., Durston, W. E., Yamasaki, E., & Lee, F. D. (1973) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.70.8.2281 · Cited by 2,276
Chromosome 17 Deletions and p53 Gene Mutations in Colorectal Carcinomas
Baker, S. J., Fearon, E. R., Nigro, J. M., Hamilton, S. R., Preisinger, A. C., Jessup, J. M., vanTuinen, P., Ledbetter, D. H., Barker, D. F., Nakamura, Y., et al. (1989) · Science · doi:10.1126/science.2649981 · Cited by 2,066
Mutational hot spot in the p53 gene in human hepatocellular carcinomas
Hsu, I. C., Metcalf, R. A., Sun, T., Welsh, J. A., Wang, N. J., & Harris, C. C. (1991) · Nature · doi:10.1038/350427a0 · Cited by 1,534
Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line
Aden, D. P., Fogel, A., Plotkin, S., Damjanov, I., & Knowles, B. B. (1979) · Nature · doi:10.1038/282615a0 · Cited by 1,317
Estimates of the worldwide frequency of sixteen major cancers in 1980
Parkin, D. M., Läärä, E., & Muir, C. S. (1988) · International Journal of Cancer · doi:10.1002/ijc.2910410205 · Cited by 1,047
Marshall, C. J. (1991) · Cell · doi:10.1016/0092-8674(91)90641-b · Cited by 751
Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma
Wang, J., Chenivesse, X., Henglein, B., & Bréchot, C. (1990) · Nature · doi:10.1038/343555a0 · Cited by 671
Cited by
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
Llovet, J. M., Kelley, R. K., Villanueva, A., Singal, A. G., Pikarsky, E., Roayaie, S., Lencioni, R., Koike, K., Zucman-Rossi, J., & Finn, R. S. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00240-3 · Cited by 7,055
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
El–Serag, H. B., & Rudolph, K. L. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.061 · Cited by 5,415
Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
El-Serag, H. B. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.12.061 · Cited by 3,380
Bennett, J. W., & Klich, M. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.3.497-516.2003 · Cited by 3,127
Llovet, J. M., Zucman-Rossi, J., Pikarsky, E., Sangro, B., Schwartz, M., Sherman, M., & Gores, G. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.18 · Cited by 2,531
WISEMAN, H., & HALLIWELL, B. (1996) · Biochemical Journal · doi:10.1042/bj3130017 · Cited by 2,345
TP53 mutations in human cancers: origins, consequences, and clinical use.
Olivier, M., Hollstein, M., & Hainaut, P. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001008 · Cited by 2,199
Hepatocellular carcinoma pathogenesis: from genes to environment
Farazi, P. A., & DePinho, R. A. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1934 · Cited by 1,979
Schulze, K., Imbeaud, S., Letouzé, E., Alexandrov, L. B., Calderaro, J., Rebouissou, S., Couchy, G., Meiller, C., Shinde, J., Soysouvanh, F., et al. (2015) · Nature Genetics · doi:10.1038/ng.3252 · Cited by 1,803
Weinberg, R. A. (1991) · Science · doi:10.1126/science.1659741 · Cited by 1,756
Mutational hot spot in the p53 gene in human hepatocellular carcinomas
Hsu, I. C., Metcalf, R. A., Sun, T., Welsh, J. A., Wang, N. J., & Harris, C. C. (1991) · Nature · doi:10.1038/350427a0 · Cited by 1,534
Guichard, C., Amaddeo, G., Imbeaud, S., Ladeiro, Y., Pelletier, L., Maad, I. B., Calderaro, J., Bioulac-Sage, P., Letexier, M., Degos, F., et al. (2012) · Nature Genetics · doi:10.1038/ng.2256 · Cited by 1,453
Seeger, C., & Mason, W. S. (2000) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.64.1.51-68.2000 · Cited by 1,451
Clinical Implications of the p53 Tumor-Suppressor Gene
Harris, C. C., & Hollstein, M. (1993) · New England Journal of Medicine · doi:10.1056/nejm199310283291807 · Cited by 1,330
Genetic landscape and biomarkers of hepatocellular carcinoma
Zucman-Rossi, J., Villanueva, A., Nault, J.-C., & Llovet, J. M. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.05.061 · Cited by 1,325
Somatic mutations of the β-catenin gene are frequent in mouse and human hepatocellular carcinomas
Coste, A. D. L., Romagnolo, B., Billuart, P., Renard, C.-A., Buendia, M.-A., Soubrane, O., Fabre, M., Chelly, J., Beldjord, C., Kahn, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8847 · Cited by 1,121
Epidemiology of Hepatocellular Carcinoma: Consider the Population
Mittal, S., & El-Serag, H. B. (2013) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3182872f29 · Cited by 1,076
Mechanisms of HBV-induced hepatocellular carcinoma
Levrero, M., & Zucman-Rossi, J. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.02.021 · Cited by 1,052
Rushing, B. R., & Selim, M. I. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2018.11.047 · Cited by 989
p53 and Human Cancer: The First Ten Thousand Mutations
(1999) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60785-x · Cited by 986
TP53 mutations in human cancers: Functional selection and impact on cancer prognosis and outcomes
Petitjean, A., Achatz, M. I. W., Borresen-Dale, A. L., Hainaut, P., & Olivier, M. (2007) · Oncogene · doi:10.1038/sj.onc.1210302 · Cited by 884
Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line.
Shaw, P., Bovey, R., Tardy, S., Sahli, R., Sordat, B., & Costa, J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4495 · Cited by 848
Bouaoun, L., Sonkin, D., Ardin, M., Hollstein, M., Byrnes, G., Zavadil, J., & Olivier, M. (2016) · Human Mutation · doi:10.1002/humu.23035 · Cited by 730
Modulation of Activity of the Promoter of the Human MDR 1 Gene by Ras and p53
Chin, K.-V., Ueda, K., Pastan, I., & Gottesman, M. M. (1992) · Science · doi:10.1126/science.1346476 · Cited by 726
Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis
Gomaa, A. I., Khan, S. A., Toledano, M. B., Waked, I., & Taylor-Robinson, S. D. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.4300 · Cited by 700
Wang, X. W., Forrester, K., Yeh, H., Feitelson, M. A., Gu, J. R., & Harris, C. C. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.6.2230 · Cited by 665
Twenty years of p53 research: structural and functional aspects of the p53 protein
May, P., & May, E. (1999) · Oncogene · doi:10.1038/sj.onc.1203285 · Cited by 663
The ATP-dependent glutathione S-conjugate export pump
Ishikawa, T. (1992) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(92)90489-v · Cited by 654
High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas.
Fagin, J. A., Matsuo, K., Karmakar, A., Chen, D. L., Tang, S. H., & Koeffler, H. P. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116168 · Cited by 649
Hussain, S. P., Schwank, J., Staib, F., Wang, X. W., & Harris, C. C. (2007) · Oncogene · doi:10.1038/sj.onc.1210279 · Cited by 621
Why are there hotspot mutations in the TP53 gene in human cancers?
Baugh, E. H., Ke, H., Levine, A. J., Bonneau, R. A., & Chan, C. S. (2018) · Cell Death & Differentiation · doi:10.1038/cdd.2017.180 · Cited by 607
Laurent–Puig, P., Legoix, P., Bluteau, O., Belghiti, J., Franco, D., Binot, F., Monges, G., Thomas, G., Bioulac–Sage, P., & Zucman–Rossi, J. (2001) · Gastroenterology · doi:10.1053/gast.2001.24798 · Cited by 582
Public Health Impacts of Foodborne Mycotoxins
Wu, F., Groopman, J. D., & Pestka, J. J. (2014) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-030713-092431 · Cited by 582
TP53 tumor suppressor gene: A model for investigating human mutagenesis
Fromentel, C. C. D., & Soussi, T. (1992) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.2870040102 · Cited by 574
Mutational processes shape the landscape of TP53 mutations in human cancer
Giacomelli, A. O., Yang, X., Lintner, R. E., McFarland, J. M., Duby, M., Kim, J., Howard, T. P., Takeda, D. Y., Ly, S. H., Kim, E., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0204-y · Cited by 556
Genomics and Signaling Pathways in Hepatocellular Carcinoma
Villanueva, A., Newell, P., Chiang, D., Friedman, S., & Llovet, J. (2007) · Seminars in Liver Disease · doi:10.1055/s-2006-960171 · Cited by 556
Ribeiro, R. C., Sandrini, F., Figueiredo, B., Zambetti, G. P., Michalkiewicz, E., Lafferty, A. R., DeLacerda, L., Rabin, M., Cadwell, C., Sampaio, G., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161479898 · Cited by 541
Hepatocellular carcinoma epidemiology
Bosetti, C., Turati, F., & La Vecchia, C. (2014) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2014.08.007 · Cited by 530
The Etiology of Hepatocellular Carcinoma and Consequences for Treatment
Sanyal, A. J., Yoon, S. K., & Lencioni, R. (2010) · The Oncologist · doi:10.1634/theoncologist.2010-s4-14 · Cited by 517
The role of oxidative stress in chemical carcinogenesis.
Klaunig, J. E., Xu, Y., Isenberg, J. S., Bachowski, S., Kolaja, K. L., Jiang, J., Stevenson, D. E., & Walborg, E. F. (1998) · Environmental Health Perspectives · doi:10.1289/ehp.98106s1289 · Cited by 511
Aguilar, F., Hussain, S. P., & Cerutti, P. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8586 · Cited by 489
Mutational spectrum of β-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas
Taniguchi, K., Roberts, L. R., Aderca, I. N., Dong, X., Qian, C., Murphy, L. M., Nagorney, D. M., Burgart, L. J., Roche, P. C., Smith, D. I., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205591 · Cited by 486
p53: At the Crossroads of Molecular Carcinogenesis and Risk Sssessment
Harris, C. C. (1993) · Science · doi:10.1126/science.8266092 · Cited by 475
The toxicology of aflatoxins as a basis for public health decisions
Wild, C. P. (2002) · Mutagenesis · doi:10.1093/mutage/17.6.471 · Cited by 475
Eferl, R., Ricci, R., Kenner, L., Zenz, R., David, J.-P., Rath, M., & Wagner, E. F. (2003) · Cell · doi:10.1016/s0092-8674(03)00042-4 · Cited by 474
The Global Epidemiology of Hepatocellular Carcinoma: Present and Future
McGlynn, K. A., & London, W. T. (2011) · Clinics in Liver Disease · doi:10.1016/j.cld.2011.03.006 · Cited by 471
Epidemiological characteristics and risk factors of hepatocellular carcinoma
CHEN, C., YU, M., & LIAW, Y. (1997) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.1997.tb00513.x · Cited by 470
Kawanishi, S., Hiraku, Y., Pinlaor, S., & Ma, N. (2006) · Biological Chemistry · doi:10.1515/bc.2006.049 · Cited by 449
p53 mutation in hepatocellular carcinoma after aflatoxin exposure
Bressac, B., Puisieux, A., Kew, M., Volkmann, M., Bozcall, S., Bella Mura, J., de la Monte, S., Carlson, R., Blum, H., Wands, J., et al. (1991) · The Lancet · doi:10.1016/0140-6736(91)92236-u · Cited by 449
Self-citationOkuda, K. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80428-6 · Cited by 443
Primary prevention of hepatocellular carcinoma
YU, S. (1995) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.1995.tb01370.x · Cited by 434
The 1993 Walter Hubert Lecture: the role of the p53 tumour-suppressor gene in tumorigenesis
Levine, A., Perry, M., Chang, A., Silver, A., Dittmer, D., Wu, M., & Welsh, D. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.76 · Cited by 422
Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers
Wang, Y., & Deng, B. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10084-4 · Cited by 415
A comparison of the biological activities of wild‐type and mutant p53
Zambetti, G. P., & Levine, A. J. (1993) · The FASEB Journal · doi:10.1096/fasebj.7.10.8344485 · Cited by 413
Viral hepatitis and liver cancer: the case of hepatitis C
Levrero, M. (2006) · Oncogene · doi:10.1038/sj.onc.1209562 · Cited by 404
Clinical Outcomes and Correlates of TP53 Mutations and Cancer
Robles, A. I., & Harris, C. C. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001016 · Cited by 394
Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer
Barton, C., Staddon, S., Hughes, C., Hall, P., O'Sullivan, C., Klöppel, G., Theis, B., Russell, R., Neoptolemos, J., & Williamson, R. (1991) · British Journal of Cancer · doi:10.1038/bjc.1991.467 · Cited by 376
Whole genome sequencing analysis for cancer genomics and precision medicine
Nakagawa, H., & Fujita, M. (2018) · Cancer Science · doi:10.1111/cas.13505 · Cited by 375
Epidemiology and natural history of hepatocellular carcinoma
McGlynn, K. A., & London, W. T. (2005) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2004.10.004 · Cited by 373
Functional inactivation but not structural mutation of p53 causes liver cancer
Ueda, H., Ullrich, S. J., Gangemi, J. D., Kappel, C. A., Ngo, L., Feitelson, M. A., & Jay, G. (1995) · Nature Genetics · doi:10.1038/ng0195-41 · Cited by 367
Nutrition and dietary carcinogens
Sugimura, T. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.387 · Cited by 365
Aberrant Promoter Methylation Profiles of Tumor Suppressor Genes in Hepatocellular Carcinoma
Yang, B., Guo, M., Herman, J. G., & Clark, D. P. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63469-4 · Cited by 365
The chemistry and biology of aflatoxin B1: from mutational spectrometry to carcinogenesis
Smela, M. E., Currier, S. S., Bailey, E. A., & Essigmann, J. M. (2001) · Carcinogenesis · doi:10.1093/carcin/22.4.535 · Cited by 362
Wang, J.-S., & Groopman, J. D. (1999) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(99)00017-2 · Cited by 354
(1992) · American Journal of Otolaryngology · doi:10.1016/0196-0709(92)90038-u · Cited by 350
Yu, J. (2012) · Toxins · doi:10.3390/toxins4111024 · Cited by 344
Heterogeneity of liver cancer and personalized therapy
Li, L., & Wang, H. (2016) · Cancer Letters · doi:10.1016/j.canlet.2015.07.018 · Cited by 339
HAMID, A. S., TESFAMARIAM, I. G., ZHANG, Y., & ZHANG, Z. G. (2013) · Oncology Letters · doi:10.3892/ol.2013.1169 · Cited by 339
Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis
Elmore, L. W., Hancock, A. R., Chang, S.-F., Wang, X. W., Chang, S., Callahan, C. P., Geller, D. A., Will, H., & Harris, C. C. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14707 · Cited by 333
Shariff, M. I., Cox, I. J., Gomaa, A. I., Khan, S. A., Gedroyc, W., & Taylor-Robinson, S. D. (2009) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.09.35 · Cited by 333
Donehower, L. A., & Bradley, A. (1993) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(93)90004-v · Cited by 333
The p53 Tumor Suppressor Gene: From Molecular Biology to Clinical Investigation
SOUSSI, T. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06705.x · Cited by 332
Genetics of hepatocellular carcinoma
Annick Buendia, M. (2000) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0319 · Cited by 329
Epidemiology of Hepatocellular Carcinoma
El-Serag, H. B. (2001) · Clinics in Liver Disease · doi:10.1016/s1089-3261(05)70155-0 · Cited by 327
From Hepatitis to Hepatoma: Lessons from Type B Viral Hepatitis
Chen, D.-S. (1993) · Science · doi:10.1126/science.8211155 · Cited by 325
Genetic mechanisms of hepatocarcinogenesis
Feitelson, M. A., Sun, B., Lale Satiroglu Tufan, N., Liu, J., Pan, J., & Lian, Z. (2002) · Oncogene · doi:10.1038/sj.onc.1205434 · Cited by 322
Jones, P. A. (2002) · Oncogene · doi:10.1038/sj.onc.1205597 · Cited by 321
p53 expression and prognosis in gastric carcinoma
Martin, H. M., Filipe, M. I., Morris, R. W., Lane, D. P., & Silvestre, F. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910500604 · Cited by 321
Abrogation of p53-Induced Apoptosis by the Hepatitis B Virus X Gene
Wang, X. W. (2003) · Hepatocellular Carcinoma · doi:10.1385/1-59259-079-9:57 · Cited by 321
Genetics of hepatocellular tumors
Laurent-Puig, P., & Zucman-Rossi, J. (2006) · Oncogene · doi:10.1038/sj.onc.1209547 · Cited by 317
Advances in Chemical Carcinogenesis: A Historical Review and Prospective
Loeb, L. A., & Harris, C. C. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2852 · Cited by 317
Medical therapies for hepatocellular carcinoma: a critical view of the evidence
Villanueva, A., Hernandez-Gea, V., & Llovet, J. M. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.199 · Cited by 314
Epidemiology, Risk Factors, and Natural History of Hepatocellular Carcinoma
MONTALTO, G., CERVELLO, M., GIANNITRAPANI, L., DANTONA, F., TERRANOVA, A., & CASTAGNETTA, L. A. M. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04090.x · Cited by 312
Crook, T., Wrede, D., Tidy, J. A., Vousden, K. H., Wrede, D., Tidy, J., Mason, W. P., & Evans, D. J. (1992) · The Lancet · doi:10.1016/0140-6736(92)90662-m · Cited by 309
Hepatocellular carcinoma: old friends and new tricks
Kim, E., & Viatour, P. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-00527-1 · Cited by 307
MicroRNA involvement in hepatocellular carcinoma
Gramantieri, L., Fornari, F., Callegari, E., Sabbioni, S., Lanza, G., Croce, C. M., Bolondi, L., & Negrini, M. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00533.x · Cited by 304
Epidemiology of Hepatocellular Carcinoma
Lafaro, K. J., Demirjian, A. N., & Pawlik, T. M. (2015) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2014.09.001 · Cited by 303
p53 oncogene mutations in three human prostate cancer cell lines
Carroll, A. G., Voeller, H. J., Sugars, L., & Gelmann, E. P. (1993) · The Prostate · doi:10.1002/pros.2990230206 · Cited by 303
Synergistic interaction between aflatoxin B1 and hepatitis B virus in hepatocarcinogenesis
Kew, M. C. (2003) · Liver International · doi:10.1111/j.1478-3231.2003.00869.x · Cited by 302
Self-citationHigashitsuji, H., Itoh, K., Nagao, T., Dawson, S., Nonoguchi, K., Kido, T., Mayer, R. J., Arii, S., & Fujita, J. (2000) · Nature Medicine · doi:10.1038/71600 · Cited by 299
Molecular Epidemiology: Insights Into Cancer Susceptibility, Risk Assessment, and Prevention
Perera, F. P. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.8.496 · Cited by 295
p53 Family and Cellular Stress Responses in Cancer
Pflaum, J., Schlosser, S., & Müller, M. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00285 · Cited by 291
p53 gene mutations and protein accumulation in human ovarian cancer.
Kupryjańczyk, J., Thor, A. D., Beauchamp, R., Merritt, V, Edgerton, S. M., Bell, D. A., & Yandell, D. W. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.11.4961 · Cited by 289
Harris, C. C. (1996) · Carcinogenesis · doi:10.1093/carcin/17.6.1187 · Cited by 285
Liver cancer: Approaching a personalized care
Bruix, J., Han, K.-H., Gores, G., Llovet, J. M., & Mazzaferro, V. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.007 · Cited by 284
Geographic Variation of p53 Mutational Profile in Nonmalignant Human Liver
Aguilar, F., Harris, C. C., Sun, T., Hollstein, M., & Cerutti, P. (1994) · Science · doi:10.1126/science.8191284 · Cited by 282
Neoplastic progression in ulcerative colitis: Histology, DNA content, and loss of a p53 allele
Burmer, G. C., Rabinovitch, P. S., Haggitt, R. C., Crispin, D. A., Brentnall, T. A., Kolli, V. R., Stevens, A. C., & Rubin, C. E. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)91184-6 · Cited by 280
Kew, M. C. (2011) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2010.06546.x · Cited by 279
Self-citationCancer Risk and Low-Penetrance Susceptibility Genes in Gene-Environment Interactions
Shields, P. G., & Harris, C. C. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.11.2309 · Cited by 275
Metadata
- Authors
- Bressac, B., Kew, M., Wands, J., & Ozturk, M.
- Venue
- Nature
- Published
- 1991-04
- Volume
- 350
- Issue
- 6317
- Pages
- 429-431
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2035794058
- Cited by
- 1,432
- References
- 22
- FWCI
- 48.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.